NCT03906344|Unknown
Expanded Access Use of INCB052793 to Treat a Single Patient With Myelofibrosis
1 other identifier
I-52793-18-02
Study Type
expanded_access
Target
N/A
Locations
0 countries
Sites
N/A
Timeline
RegisteredApr 2019
Brief Summary
Expanded access use of INCB052793 to treat a single patient with Myelofibrosis.
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 4, 2019
Completed4 days until next milestone
First Posted
Study publicly available on registry
April 8, 2019
CompletedLast Updated
April 8, 2019
Status Verified
April 1, 2019
First QC Date
April 4, 2019
Last Update Submit
April 4, 2019
Interventions
INCB052793DRUG
Eligibility Criteria
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Savona, MD
Vanderbilt University Medical Center
Study Design
- Study Type
- expanded access
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 4, 2019
First Posted
April 8, 2019
Last Updated
April 8, 2019
Record last verified: 2019-04